The Mammography Quality Standards Act and interventional mammography procedures.
The Food and Drug Administration (FDA) is in the early stages of developing regulations regarding mammographic interventional procedures. When implemented, the regulations have a significant impact on the way these procedures are performed. As part of the development process, the FDA is working with the American College of Surgeons (ACS), the American College of Radiology (ACR), and other interested professional and consumer groups. The goal is to ensure access to high-quality services for the diagnosis of breast cancer.